Back to search results

MAsS Scan Study for Liver Disease

This study is looking at how a special measurement called the Muscle Assessment Score (MAsS), taken during an MRI (Magnetic Resonance Imaging) scan, can help predict health problems and survival in people with liver disease. The MAsS score measures your muscle health and frailty (weakness). Researchers want to see if this score can tell them more about how liver disease might affect you over time. You can join if you are 18 or older and are already scheduled for an MRI for other medical reasons. The study aims to enroll 1200 participants. The main goal is to see if the MAsS score can predict how long people on a transplant waitlist will live, with measurements taken up to 10 years after you join.

Study design
This is an observational study, meaning researchers will watch and collect information from 1200 participants. It is not a study testing a new treatment.
What's involved
If you participate, an additional 8-10 minutes will be added to your already scheduled MRI scan.
Compensation
Not stated in the trial record.
Follow-up
Your health will be monitored for up to 10 years after you join the study to see how the MAsS score relates to survival.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05264051

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

Recruiting
Not specifiedAges 18+Observational
University of Chicago
~1,200 participants
Updated 2026-01-14 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Waitlist Mortality
Measured over Measured up to 10 years out from enrollment

Conditions

Liver Diseases

Explore related trials

Liver and Intrahepatic Bile Duct Disorder

NCT05264051

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • The University of Chicago

    Chicago, Illinoisstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Omar Jamil, MD
[email protected]
847-373-2360
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients who are already scheduled for an MRI for routine clinical purposes will be evaluated

Exclusion

\<18 yrs. of age

What this trial measures

  • Waitlist MortalityMeasured up to 10 years out from enrollment

    Death prior to liver transplant or delisting from enrollment in the study